Viewing Study NCT01408160


Ignite Creation Date: 2025-12-25 @ 2:12 AM
Ignite Modification Date: 2025-12-27 @ 10:59 PM
Study NCT ID: NCT01408160
Status: TERMINATED
Last Update Posted: 2019-09-06
First Post: 2011-07-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
Sponsor: Albert Einstein College of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module